☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Metastatic Castration-Sensitive Prostate Cancer
Janssen's Erleada (apalutamide) Receives Health Canada's Approval for Metastatic Castration-Sensitive Prostate Cancer
December 17, 2019
Janssen (J&J) Reports Results of Erleada (apalutamide) in P-III TITAN Study for Metastatic Castration-Sensitive Prostate Cance...
January 31, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.